Oncology News | pharmaphorum

News

EU regulators back BMS' Opdivo in new skin cancer use

Bristol-Myers Squibb’s cancer immunotherapy Opdivo is likely to gain another use in Europe after regulators recommended it after surgery for skin cancer.

News

CAR-Ts close to EU approval, face further US price scrutiny

Revolutionary CAR-T cell therapies for blood cancer could be on the European market within a few months after they were given the green light by regulators – but they face further price scr

Market Access

NICE okays Roche rare lung cancer drug after price cut

Alecensa has aced Pfizer's rival in head-to-head trial

News

AbbVie leads $53m investment macrophage cancer tech

A duo of University of Pennsylvania scientists have stepped out with multi-million dollar backing from investors including AbbVie, on a mission to kill tumour cells using re-engineered macrophag

AstraZeneca